Vascular Biogenics Other Current Assets

Vascular Biogenics (VBLT) currently reports a other current assets of $2.9M as of June 2024. That compares with $280K in the prior-year period — up 918.3% year over year. Use the charts on this page to explore Vascular Biogenics's other current assets history and peer comparisons.

Vascular Biogenics's other current assets increased from $280K to $2.9M — a 918.3% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vascular Biogenics reported $2.9M in other current assets as of June 2024. That compares with $280K in the prior-year period — up 918.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $2.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vascular Biogenics, and consider following VBLT for alerts when major investors trade the stock.

Vascular Biogenics is classified in the Healthcare sector. On other current assets, it currently shows $2.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBLT with unrelated industries.